Pfizer Signs Marketing and Supply Deal with Mylan Pharmaceuticals
Under the terms of the agreement, Pfizer will retain ownership of the brands, while Mylan will be responsible for their marketing and sales within India for a period of five years.
Pfizer | 25/02/2025 | By Aishwarya
Alloy Therapeutics and Pfizer to Develop New Antibody Discovery Platform
Pfizer and Alloy have collaborated on various antibody discovery efforts, including the use of Alloy's ATX-CLC platform.
Pfizer | 12/02/2025 | By Aishwarya
Acepodia Signs Strategic Clinical Partnership with Pfizer for Autoimmune Diseases
Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its cell therapies for oncology and autoimmune diseases.
Pfizer | 04/09/2024 | By Aishwarya | 100
Flagship Pioneering and Quotient Therapeutics Signs Deal with Pfizer
Pioneering Medicines, Flagship’s in-house drug discovery and development unit, is responsible for leading the strategic partnership with Pfizer, including driving the exploration process to rapidly surface potential drug development programs built on Flagship’s diverse bioplatforms and modalities.
Pfizer | 29/08/2024 | By Aishwarya | 106
Pfizer | 21/07/2023 | By Sudeep Soparkar | 333
Meenakshi Nevatia joins Pfizer as MD and Additional Director, effective April 3
Nevatia has nearly 30 years of business leadership and consulting experience with top companies
Pfizer | 13/02/2023 | By Sudeep Soparkar | 431
Pfizer inks deal to acquire Abzena's manufacturing plant in North Carolina
Construction is ongoing at the location, which Abzena selected back in April 2021 for its access to a talented workforce and other resources
Pfizer | 18/01/2023 | By Sudeep Soparkar | 591
Dr Reddy's acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products India
Following the trademark rights acquisition, Dr Reddy’s will manufacture the Active Pharmaceutical Ingredient (API) and finished drug at its state-of-the-art facilities
Pfizer | 17/01/2023 | By Sudeep Soparkar | 376
Pfizer to invest $750 M to upgrade Michigan facility
The project is expected to create around 300 new jobs
Pfizer | 08/12/2022 | By Sudeep Soparkar | 558
Glenmark Pharma in agreement with Pfizer for Axitinib tabs, 1 mg and 5 mg
The Inlyta tablets, 1 mg and 5 mg market 2 achieved annual sales of approximately $644.5 million
Pfizer | 22/11/2022 | By Sudeep Soparkar | 463
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy